Cargando…
Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors
The cell and gene therapy industry has employed the same plasmid technology for decades in vaccination, cell and gene therapy, and as a raw material in viral vector and RNA production. While canonical plasmids contain antibiotic resistance markers in bacterial backbones greater than 2,000 base pairs...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280095/ https://www.ncbi.nlm.nih.gov/pubmed/37346980 http://dx.doi.org/10.1016/j.omtn.2023.04.003 |